Montenegro vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Montenegro
100.0%
in 2023
South-East Asia (WHO region)
94.0%
in 2024
Montenegro rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Montenegro
- South-East Asia (WHO region)
How they compare
Montenegro currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Montenegro's figure about 1.1 times South-East Asia (WHO region)'s.
The two have swapped places 2 times across 6 shared years of data; in 2006 it was Montenegro ahead.
Montenegro ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Across the 3 decades both report, Montenegro averaged higher in 2 and South-East Asia (WHO region) in 1.
Head to head by decade
| Decade | Montenegro | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 31.0% | 69.0% | Montenegro |
| 2010s | 100.0% | 73.7% | 26.3% | Montenegro |
| 2020s | 75.0% | 94.5% | 19.5% | South-East Asia (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Montenegro or South-East Asia (WHO region)?
- Montenegro, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Montenegro and South-East Asia (WHO region)?
- 6.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and South-East Asia (WHO region)?
- 6 years are reported by both, from 2006 to 2023.
- How do Montenegro and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Montenegro ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.